|
SOX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.78605999999748E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.83251200272616E-12 |
| Stage1-vs-Stage2 |
9.621600E-03 |
| Stage1-vs-Stage3 |
6.387200E-01 |
| Stage1-vs-Stage4 |
7.606400E-01 |
| Stage2-vs-Stage3 |
1.348080E-02 |
| Stage2-vs-Stage4 |
3.194200E-02 |
| Stage3-vs-Stage4 |
9.519000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.397300E-04 |
| Normal-vs-Asian |
1.15640830244956E-12 |
| Caucasian-vs-AfricanAmerican |
7.538800E-01 |
| Caucasian-vs-Asian |
7.593800E-01 |
| AfricanAmerican-vs-Asian |
6.592600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.637400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63746793901964E-12 |
| Normal-vs-Age(81-100Yrs) |
4.098000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.233600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.634100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.310600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.246000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.523400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.832100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.689200E-01 |
| Classical-VS-Follicular |
3.33066907387547E-16 |
| Classical-VS-Other |
6.601000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.01254593388012E-12 |
| Tall-VS-Other |
3.249200E-01 |
| Tall-VS-Normal |
1.62481139653892E-12 |
| Follicular-VS-Other |
1.082330E-02 |
| Follicular-VS-Normal |
2.343100E-03 |
| Other-VS-Normal |
9.941800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.75859327100625E-13 |
| N0-vs-N1 |
1.537580E-03 |
|
|
